Traub Capital Management LLC Takes Position in CVS Health Corporation $CVS

Traub Capital Management LLC acquired a new position in CVS Health Corporation (NYSE:CVS) in the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 10,464 shares of the pharmacy operator’s stock, valued at approximately $722,000.

Several other large investors also recently added to or reduced their stakes in CVS. Avion Wealth raised its position in CVS Health by 99.0% during the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after buying an additional 189 shares during the period. Harbor Asset Planning Inc. acquired a new position in shares of CVS Health in the 2nd quarter valued at about $30,000. Bell Investment Advisors Inc lifted its position in shares of CVS Health by 119.8% in the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 248 shares in the last quarter. Roxbury Financial LLC boosted its holdings in shares of CVS Health by 78.3% during the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 202 shares during the period. Finally, ORG Partners LLC increased its stake in CVS Health by 418.9% in the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock valued at $32,000 after buying an additional 377 shares during the period. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Stock Down 0.6%

NYSE CVS opened at $77.93 on Wednesday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.62 and a current ratio of 0.83. The stock has a market cap of $98.93 billion, a PE ratio of 205.08, a PEG ratio of 0.87 and a beta of 0.60. The firm has a 50-day simple moving average of $77.98 and a 200 day simple moving average of $70.09. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $85.15.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.24. The firm had revenue of $102.87 billion for the quarter, compared to analyst estimates of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The company’s revenue was up 7.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.09 EPS. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, research analysts forecast that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd were paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.4%. The ex-dividend date of this dividend was Thursday, October 23rd. CVS Health’s dividend payout ratio is 700.00%.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the stock. UBS Group lifted their target price on shares of CVS Health from $79.00 to $96.00 and gave the company a “buy” rating in a research note on Friday, October 24th. Royal Bank Of Canada boosted their target price on CVS Health from $81.00 to $93.00 and gave the company an “outperform” rating in a research note on Thursday, October 30th. Jefferies Financial Group increased their price objective on CVS Health from $92.00 to $98.00 in a report on Thursday, October 30th. Mizuho raised their price target on shares of CVS Health from $76.00 to $88.00 and gave the company an “outperform” rating in a report on Thursday, October 9th. Finally, The Goldman Sachs Group began coverage on CVS Health in a report on Tuesday, October 14th. They set a “buy” rating and a $91.00 target price on the stock. Two investment analysts have rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $89.41.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.